✦ LIBER ✦

Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review

✍ Scribed by Deborah J. Pinchon; Simon J. Stanworth; Carolyn Dorée; Susan Brunskill; Derek R. Norfolk

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 103 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21503

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicted costs of iron-chelators in mye

Predicted costs of iron-chelators in myelodysplastic syndromes: A 10-year analysis based on actual prevalence and red cell transfusion rates

✍ Senthilkumar Durairaj; Stephen Chew; Ann Hyslop; Norene Keenan; Michael J. Grove 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## Abstract Consideration of iron‐chelation (IC) in transfusion‐dependent patients is recommended in most clinical‐practice guidelines on myelodysplastic syndromes (MDS). The financial impact of IC on health‐care systems is predicted through economic modeling, but an analysis based on actual preval

Long term follow-up of allogeneic stem c

Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide

✍ Ehab Atallah; Judith Abrams; Lois Ayash; Gail Bentley; Muneer Abidi; Voravit Rat 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Deletion of 5q31 is observed in megakary

Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome

✍ Catherine Godon; Pascaline Talmant; Richard Garand; Françoise Accart; Régis Bata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB